10 research outputs found
Patients with VL >5.000 copies/ml (N = 55).
<p>Patients with VL >5.000 copies/ml (N = 55).</p
RAMS among patients with virological failure (VL>5.000 copies/ml) amplified and evaluated by genotyping.
<p>RAMS among patients with virological failure (VL>5.000 copies/ml) amplified and evaluated by genotyping.</p
Virological failure rates over time in different resource limited settings.
2<p>
<b>Ferradini et al. Lancet 2006; 367:1335–42. <sup>3</sup> Ferradini et al. AIDS 2007, 21:2293–2301.</b></p
Baseline cohort characteristics.
<p>IQR, interquartile range; ART, antiretroviral therapy; BMI, body mass index, ARV, antiretroviral drug.</p
Characteristics of patients with and without virological failure at the time of the study.
<p>Characteristics of patients with and without virological failure at the time of the study.</p
Sensitivity, specificity, and predictive values of immunological and clinical criteria in identifying virological treatment failure.
<p>TP = true positive, FN = false negative, FP = false positive, TN = true negative.</p><p>Results are based in one CD4 and viral load result.</p
Kaplan Meier analysis from six months of therapy to clinical failure.
<p>Kaplan Meier analysis from six months of therapy to clinical failure.</p